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Abstract
The human immunodeficiency virus 1 (HIV-1) transcriptional transactivator (Tat) is essential for synthesis of full-length
transcripts from the integrated viral genome by RNA polymerase II (Pol II). Tat recruits the host positive transcription
elongation factor b (P-TEFb) to the HIV-1 promoter through binding to the transactivator RNA (TAR) at the 59-end of the
nascent HIV transcript. P-TEFb is a general Pol II transcription factor; its cellular activity is controlled by the 7SK small nuclear
RNA (snRNA) and the HEXIM1 protein, which sequester P-TEFb into transcriptionally inactive 7SK/HEXIM/P-TEFb snRNP.
Besides targeting P-TEFb to HIV transcription, Tat also increases the nuclear level of active P-TEFb through promoting its
dissociation from the 7SK/HEXIM/P-TEFb RNP by an unclear mechanism. In this study, by using in vitro and in vivo RNA-protein
binding assays, we demonstrate that HIV-1 Tat binds with high specificity and efficiency to an evolutionarily highly conserved
stem-bulge-stem motif of the 59-hairpin of human 7SK snRNA. The newly discovered Tat-binding motif of 7SK is structurally
and functionally indistinguishable from the extensively characterized Tat-binding site of HIV TAR and importantly, it is
imbedded in the HEXIM-binding elements of 7SK snRNA. We show that Tat efficiently replaces HEXIM1 on the 7SK snRNA in
vivo and therefore, it promotes the disassembly of the 7SK/HEXIM/P-TEFb negative transcriptional regulatory snRNP to
augment the nuclear level of active P-TEFb. This is the first demonstration that HIV-1 specifically targets an important cellular
regulatory RNA, most probably to promote viral transcription and replication. Demonstration that the human 7SK snRNA
carries a TAR RNA-like Tat-binding element that is essential for the normal transcriptional regulatory function of 7SK questions
the viability of HIV therapeutic approaches based on small drugs blocking the Tat-binding site of HIV TAR.
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Introduction
Synthesis of mRNAs by Pol II is tightly controlled at the step of
transcription elongation by the positive transcription elongation
factor b (P-TEFb) that is a cyclin-dependent kinase composed of
Cdk9 and cyclin T1 (CycT1) [1,2,3,4,5]. After transcription
initiation and promoter clearance, Pol II is arrested by the
negative elongation factor (NELF) and the DRB sensitivity-
inducing factor (DSIF). To restore productive Pol II elongation,
P-TEFb phosphorylates NELF, DSIF and the heptapeptide
repeats (YSPTSPS) in the C-terminal domain (CTD) of Pol II at
serine 2. P-TEFb is a general transcription factor that is required
for efficient expression of most protein-coding genes as well as for
production of full-length transcripts from the integrated HIV-1
genome [6,7].
In the nuclei of HeLa cells, about half of P-TEFb forms a
kinase-inactive ribonucleoprotein (RNP) with the 7SK snRNA
[8,9]. The 7SK/P-TEFb snRNP also contains the hexamethylene
bisacetamide (HMBA)-inducible protein HEXIM1 and less often,
HEXIM2 [10,11,12,13], the La-related protein Larp7 [14,15,16]
and the methylphosphate capping enzyme MePCE [17,18]. While
Larp7 and MePCE bind stably to and provide stability for 7SK
snRNA, P-TEFb and HEXIM1/2 show a dynamic, transcription-
dependent association with 7SK. Blocking of Pol II transcription
induces dissociation of P-TEFb and HEXIM proteins from the
7SK snRNP to increase the nuclear level of active P-TEFb
[8,9,10,11]. On the contrary, inhibition of cell growth shifts P-
TEFb from active to inactive 7SK-associated complexes [19,20].
Thus, the 7SK snRNA and HEXIM1/2 proteins function as key
regulators of Pol II transcription through controlling the nuclear
activity of P-TEFb. Malfunction of the 7SK–P-TEFb regulatory
machine that abnormally increases P-TEFb activity can lead to
development of cardiac hypertrophy or to malignant transforma-
tion of the cell [16,21].
The human 7SK is a 331 nt-long Pol III-transcribed abundant
snRNA [22]. P-TEFb is tethered to 7SK through interacting with
HEXIM1 and HEXIM2 that directly bind to the 59 hairpin of 7SK
snRNA in the forms of homo- or heterodimers [11,12,13,23,
24,25,26,27]. HEXIM proteins interact with two copies of P-TEFb
and inhibit their protein kinase activity strictly in a 7SK snRNA-
dependent manner [11,27]. Binding of 7SK to the positively charged
RNA-binding motif of HEXIM1/2 enables the acidic P-TEFb-
binding domain of HEXIM1/2 to interact with CycT1 [28]. In vivo
docking and inactivation of P-TEFb by the 7SK snRNP also requires
the binding of CycT1, either directly or indirectly, to the 39 hairpin of
7SK snRNA [26].
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promoter of the integrated HIV-1 genome is controlled predom-
inantly at the level of elongation [1,29,30]. The processivity of
HIV transcription depends on the viral transactivator Tat that
recruits P-TEFb to the stalled Pol II [31,32]. To capture P-TEFb,
the activation domain of Tat associates with CycT1 and its RNA-
binding motifs binds to the transactivation response element,
TAR, an RNA hairpin at the 59 end of the nascent HIV LTR
transcript [33,34,35,36]. Besides tethering P-TEFb to the TAR
RNA, recent studies demonstrated that Tat also promotes the
disassembly of the 7SK/HEXIM/P-TEFb snRNP to increase the
nuclear level of active P-TEFb [37,38]. Indeed, efficient
transcription from the HIV LTR promoter requires considerably
higher P-TEFb activity than that is needed for cellular mRNA
production and host cell viability [6,31,39,40,41].
The molecular mechanism of Tat-mediated regulation of
nuclear P-TEFb activity is unclear. Tat has been proposed to
compete with HEXIM to displace it either from the CycT1
subunit of P-TEFb or from the 7SK snRNA [37,38]. In this study,
we demonstrate that in HIV-infected cells, the 7SK transcriptional
regulatory snRNA is the major RNA target of the accumulating
Tat protein. HIV Tat binds with high specificity and efficiency to
an evolutionarily highly conserved TAR RNA-like stem-bulge-
stem motif of the 59 hairpin of 7SK snRNA. We demonstrate that
the newly discovered Tat-binding site of 7SK is imbedded in the
HEXIM-binding elements of 7SK and therefore, Tat promotes
disassembly of the 7SK/HEXIM/P-TEFb negative transcription-
al regulatory snRNP through displacing the HEXIM homodimer
from the 7SK snRNA.
Results
HIV Tat specifically associates with 7SK snRNA in vivo
To test whether Tat can interact with 7SK snRNA in living
cells, Flag-tagged Tat (Tat-FL) was transiently expressed in human
HeLa cells and recovered by immunoprecipitation (IP) with an
anti-Flag antibody (Figure 1A). As demonstrated by Western blot
analysis, the expressed Tat-FL protein interacted with the Paf1
component of the recently reported Tat/P-TEFb-associated
elongation complex, indicating that it was functionally active
[42]. HeLa RNAs co-precipitated with Tat-FL were 39 end-
labeled with [59-
32P]pCp and T4 RNA ligase and analyzed on a
denaturing gel (Figure 1B, lane 2). Autoradiography revealed that
Tat-FL bound to a unique RNA with an electrophoretic mobility
corresponding to the 331 nt-long human 7SK snRNA. To
determine unequivocally its identity, the terminally labeled Tat-
associated RNA was partially digested with the G-specific
endoribonuclease T1 or it was moderately hydrolyzed with alkali
before fractionation on a sequencing gel (Figure 1C). Distribution
of the G residues in the 39-terminal part of the Tat-associated
HeLa RNA perfectly matched with the nucleotide sequence of
human 7SK snRNA. The faint band duplications above the
RNase T1 digestion products indicate sequence heterogeneity at
the 39 end of 7SK snRNA [43].
To rule out that Tat-FL associated with 7SK in the cell extract,
we performed in vivo cross-linking experiments (Figure 1D). HeLa
cells expressing Tat-FL were treated with formaldehyde and after
extract preparation, Tat-FL was immunoprecipitated under highly
stringent conditions [44]. RNase A/T1 protection analysis
confirmed that 7SK snRNA was efficiently cross-linked to Tat-
FL in vivo (lane 5). In control IPs performed in the absence of
antibody (lane 4) or from non-cross-linked cell extract (lane 2), no
7SK-Tat-FL interaction was detected under the applied harsh
wash conditions. We concluded that Tat specifically and most
probably, directly interacts with 7SK snRNA in living cells.
The 59 hairpin of human 7SK snRNA carries a conserved
Tat-binding element
To define the region of 7SK snRNA which interacts with Tat,
we assayed the in vivo interaction of transiently expressed truncated
7SK RNAs with Tat-FL by IP with an anti-Flag antibody followed
by Northern blot analysis (Figure 2A). Co-precipitation of the
endogenous HeLa 7SK snRNA with Tat-FL provided a positive
control for each IP reaction. Removal of the 39 hairpin of 7SK,
although largely compromised the stability of the truncated d39HP
RNA (lanes 9 and 11), failed to prevent its association with Tat-FL
(lane 12). In contrast, deletion of the 59 hairpin eliminated the
interaction of d59HP RNA with Tat-FL (lane 8). Finally, the 59HP
RNA that represented the 59 hairpin of 7SK efficiently interacted
with Tat-FL (lane 4), demonstrating that HIV Tat binds to the 59
hairpin of 7SK snRNA.
Tat recognizes an internal stem-bulge-stem motif of HIV TAR
RNA (Figure 2B). The first uridine in the bulge and the G-C and A-
U base-pairs in the upper stem are indispensable for Tat binding
[45,46,47,48]. A structural rearrangement of the bulge loop
provides the specificity for the Tat-TAR interaction. The bulged
U forms a base-triple interaction with the A-U base-pair that
stabilizes the association of the lower G residue in the major grove
with an arginine of Tat [49,50]. We noticed that the 59 hairpin of
human 7SK snRNA carries two internal segments, G18-A27/U84-
C90 and C37–C45/G64–G70, which are highly reminiscent of the
consensus minimal structure of the Tat-binding element of HIV
TAR (Figure 2C, shaded boxes). The putative distal (upper) Tat-
binding element of human 7SK shows a striking conservation in all
known 7SK snRNAs derived from phylogenetically distant species.
To test whether the newly detected potential Tat-binding motifs
of human 7SK snRNA can interact with Tat, we performed
electrophoretic mobility shift assays using in vitro synthesized probe
RNAs representing either the distal (Dist) or the proximal (Prox)
parts of the 59 hairpin of 7SK and a Tat-derived oligopeptide,
Tat(38–72) [51] (Figure 3A). The Tat peptide efficiently bound to
the distal part of the 59 hairpin of 7SK (lanes 2–4), but failed to
associate with its proximal part (lane 7–9). Administration of cold
Dist RNA abolished association of the Tat oligopeptide with 7SK
sequences, confirming that Tat binds specifically to the distal part
of the 59 hairpin of human 7SK snRNA (lane 5).
The 59 hairpin of human 7SK contains two 10 nt-long perfect
repeats (G13–G22 and G64–G73) which overlap the distal and
proximal putative Tat-binding elements (Figure 3A, indicated by
Author Summary
Expression and replication of the human immunodeficien-
cy virus (HIV) is supported by the viral transcriptional
transactivator (Tat) that recruits the host positive tran-
scription elongation factor b (P-TEFb) to the promoter of
the integrated viral genome. Here, we demonstrate that
HIV Tat specifically and efficiently binds to the host 7SK
small nuclear RNA (snRNA) that is a negative regulator of
P-TEFb. Although HIV Tat has been reported to interact
with a plethora of host factors, our results indicate that the
7SK transcriptional regulatory snRNA is a major and
important cellular target of HIV Tat. We demonstrate that
binding of Tat to the 7SK snRNA disrupts the 7SK-P-TEFb
negative transcriptional regulatory complex and releases
active P-TEFb. Thus, we propose that Tat not only targets
P-TEFb for HIV transcription, but also modulates the
nuclear level of active P-TEFb in HIV-infected cells.
HIV Tat Binds to the HEXIM-Binding Site of 7SK
PLoS Pathogens | www.plospathogens.org 2 October 2010 | Volume 6 | Issue 10 | e1001152arrows). The wild-type GAUCUGGCUG repeat sequences were
replaced with complementary sequences in the p59HP expression
plasmid (Figure 3B). The mutant 59HPdm (distal mutant) and
59HPpm (proximal mutant) RNAs were transiently expressed in
HeLa cells and their association with the co-expressed Tat-FL
protein was tested. Northern blot analysis demonstrated that Tat-
FL interacted with 59HPpm RNA (lane 4), but it failed to associate
with the 59HPdm and the double mutant 59HPpm+dm RNAs
(lanes 8 and 12), providing strong support to the notion that Tat
interacts with the distal Tat-binding motif of human 7SK snRNA.
To confirm that Tat binds to the C37–C45/G64–G70 TAR
RNA-like motif of human 7SK, a series of mutant 59HP RNAs
were transiently expressed and their association with Tat-FL was
examined (Figure 3C). Substitution of the U40, U40–U41 bulge
nucleotides or the A43, G42-A43, U63-C67 and U68-G70 stem
nucleotides for complementary sequences fully abolished the in vivo
association of the expressed mutant 59HP RNAs with Tat-FL
(lanes 4, 12, 16, 20, 24 and 28). In contrast, substitution of the
U72-C75 nucleotides failed to interfere with Tat binding (lane 8).
Likewise, replacing the U63 bulge nucleotide, the G60-C62 stem
or the A49-C59 loop sequences with complementary nucleotides
had no effect on in vivo Tat binding (data not shown). We
concluded that Tat binds to the evolutionarily conserved C37–
C45/G64–G70 motif of 7SK that is structurally indistinguishable
from the Tat-binding element of HIV TAR.
The 59 hairpin of human 7SK snRNA carries two HEXIM-
binding sites
The strong evolutionarily conservation of the newly identified
Tat-binding site of human 7SK suggests that this element plays an
important role in the normal function of 7SK snRNA (Figure 2C).
The positively charged arginine-rich TAR-recognition motif of
HIV Tat shows strong similarity to the N-terminal part of the
7SK-binding motif of HEXIM proteins derived from evolution-
arily distant species (Figure S1) [52]. This suggests that Tat and
HEXIM recognize similar, if not identical, target motif(s) in the 59
hairpin of 7SK. HEXIM1 has been reported to be a promiscuous
double-stranded RNA-binding protein that binds to 7SK between
nucleotides 10 to 48 in a sequence-independent manner [53]. In
contrast, we had earlier observed that in HeLa cells HEXIM1
binds to the distal part of the 59 hairpin of 7SK with high
specificity [26]. To clarify these inconsistencies and to define the
precise binding site of HEXIM, we performed electrophoretic
mobility shift assays (Figure 4A). When the entire 59 hairpin of
7SK (59HP) was incubated with increasing amounts of recombi-
nant HEXIM1, two 59HP-HEXIM1 complexes, indicated as shift
1 and 2, were detected on a native gel (lanes 2–6). In the presence
of about two-fold excess of HEXIM1 only the upper low-mobility
complex (shift 2) was formed (lane 6). Administration of cold 59HP
RNA inhibited 59HP-HEXIM1 complex formation (lanes 7–9),
indicating that in accordance with previous reports, the 59 hairpin
Figure 1. In vivo association of HIV Tat with 7SK. A. Transient expression of Tat-FL in HeLa cells. Schematic structure of the pTat-FL expression
construct is shown. The cytomegalovirus promoter (CMV) and the polyadenylation region (PA) are indicated. Tat-FL was immunoprecipitated (a-Flag)
from extracts (E) prepared from transfected or non-transfected (NT) cells. Distribution of Tat-FL and Paf1 was monitored by Western blot analysis. B.
Detection of Tat-associated HeLa RNAs. RNAs co-precipitated with Tat-FL (T) were labeled in vitro and separated on a 6% sequencing gel. Lanes NT
and M, control IP from non-transfected cells and molecular size markers. C. RNA G-tracking. The Tat-associated RNA was partially digested with RNase
T1 or moderately hydrolyzed with formamide (OH
2) and analyzed on a 6% gel. G residues and their positions in the human 7SK snRNA sequence are
indicated. Asterisk indicates a fragile U residue. D. In vivo cross-linking of Tat-FL and 7SK. HeLa cells expressing Tat-FL were treated (x link) or not
treated (cont) with formaldehyde before extract (E) preparation. Tat-FL was immunoprecipitated (a-Flag) or mock-precipitated (no Ab) under
stringent conditions. Distributions of Tat-FL and 7SK snRNA were monitored by Western blot analysis and RNase A/T1 mapping, respectively.
doi:10.1371/journal.ppat.1001152.g001
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[13,24,25].
When probe RNAs representing the proximal (Prox) and distal
(Dist) regions of the 59 hairpin of 7SK were incubated with
HEXIM1, HEXIM1 specifically associated with both RNAs (lanes
11–13 and lanes 16–18). The resulting Dist-HEXIM1 and Prox-
HEXIM1 complexes co-migrated with the high-mobility complex
(shift1) formed by the full-length 59 hairpin and HEXIM1.
Importantly, neither the Dist nor the Prox probe RNA formed the
large low-mobility complex (shift 2) with HEXIM1, demonstrating
that the 59 hairpin of 7SK contains two structurally and
functionally independent HEXIM-binding sites each recruiting
one HEXIM molecule in an independent fashion in vitro.
We tested whether the newly defined distal Tat-binding element
and the proximal Tat-binding-like motif of the 59 hairpin of 7SK
are essential for HEXIM1 binding. Mutant 59 hairpin RNAs,
59HPdm and 59HPpm (see Figure 3), were incubated with
HEXIM1 and the resulting complexes were analyzed on a native
gel (Figure 4B). Both 59HPdm and 59HPpm RNAs formed only
the high-mobility complex with HEXIM1 (shift 1), indicating that
they bind only one copy of HEXIM1 (lanes 3–4 and 8–9). As
expected, the double-mutant 59HPpm+dm RNA was inactive in
HEXIM-binding (lanes 12–14). These results confirmed that the
newly identified Tat-binding motif in the distal part and the Tat-
binding-like element in the proximal part of the 7SK 59 hairpin
function in HEXIM-binding.
Figure 2. Identification of putative Tat-binding motifs in 7SK snRNA. A. Tat binds to the 59 hairpin of 7SK. Schematic structures of the
p7SK expression construct and the expressed truncated 7SK RNAs are shown. Dashed boxes indicate deletions. Pol III transcription of the 7SK gene
terminates within four consecutive T residues. HeLa cells were transfected with the indicated expression plasmids. After extract (E) preparation,
Tat-FL was immunoprecipitated (IP). Distribution of the endogenous and transiently expressed 7SK RNAs and Tat-FL was monitored by Western
and Northern blotting. B. Consensus structure of the minimal Tat-binding motif of HIV TAR. Nucleotides with essential and moderate contribution
to Tat binding are in red and green, respectively. C. Phylogenetic comparison of the 59 hairpins of 7SK snRNAs. The sequences of lancelet, snail,
fruit fly and tick 7SK snRNAs have been published [65,66]. The potential Tat-binding motifs of human 7SK snRNA are shaded. The evolutionarily
invariant nucleotides are in red. Nucleotides common to the putative proximal Tat-binding motif of 7SK and the Tat-binding site of HIV TAR are in
orange.
doi:10.1371/journal.ppat.1001152.g002
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HEXIM-binding, the distal A34-C45/G64-A77 and proximal
C12-A27/U84-U95 fragments of 7SK were topped with GGAA
tetraloops and stabilized with artificial basal stems (Figure 4C).
The resulting distal and proximal HEXIM-binding site (DHBS
and PHBS) RNAs specifically associated with HEXIM1 (lanes 4
and 9). Any further truncations or sequence alterations abolished
the HEXIM-binding capacity of the DHBS and PHBS RNAs,
indicating that the A34-C45/G64-A77 and C12-A27/U84-U95
internal segments of the 59 hairpin of 7SK contain the minimal
sequence and structural information required for in vitro recogni-
tion by HEXIM1 (data not shown). This conclusion was further
corroborated by demonstration that similarly to the control wild-
type 59 hairpin (Figure 4D, lane 9), an artificial hairpin RNA
(59HPsyn) encompassing the C12-A25/U86-U95 and A34-C45/
G64-A77 fragments of human 7SK was capable of binding two
HEXIM1 molecules (lane 4).
The distal and proximal HEXIM-binding sites of 7SK work
in an interdependent fashion in vivo
Our in vitro binding studies revealed that the 59 hairpin of
human 7SK snRNA carries two structurally and functionally
independent HEXIM-binding sites. However, we had earlier
observed that mutations predicted to disrupt the distal HEXIM-
binding element of the 59 hairpin fully abolished the in vivo
HEXIM-binding capacity of 7SK snRNA [26]. A possible
interpretation of these contradictory results could be that in vivo
the two HEXIM-binding sites of 7SK function in an interdepen-
dent way. To test this assumption, we investigated the in vivo
HEXIM-binding ability of the mutant 59HPpm and 59HPdm
RNAs which still bind one copy of HEXIM1 under in vitro
conditions (see Figure 4B). The 59HPpm and 59HPdm RNAs were
transiently expressed in HeLa cells and their association with a co-
expressed HA-tagged HEXIM1 was monitored (Figure 5A). The
ectopically expressed HA-HEXIM1 protein efficiently associated
Figure 3. Characterization of the Tat-binding element of human 7SK snRNA. A. Tat binds to the distal part of the 59 hairpin of 7SK.
About 2 fmol of
32P-labeled RNA representing the distal (Dist) or proximal (Prox) part of the 7SK 59 hairpin was incubated with the indicated
amount (fmol) of Tat(38–72) oligopeptide and analyzed on a 4% native gel. B. The distal Tat-binding motif of 7SK directs in vivo binding of Tat.
The 59 hairpin of 7SK (59HP) carrying the pm and/or dm mutations was co-expressed with Tat-FL and their interaction was tested by co-IP and
Northern blotting. Structure of the p59HP expression plasmid with the pm and dm mutations and the expected length of the 59HP RNA is shown.
C. In vivo association of Tat with mutant 7SK 59 hairpin RNAs. Nucleotides indicated by red (essential) or green (dispensable) lines were replaced
with complementary nucleotides in the p59HP expression plasmid. Tat-FL and the mutant 59HP RNAs were co-expressed in HeLa cells and their
interactions were tested.
doi:10.1371/journal.ppat.1001152.g003
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the transiently expressed wild-type 59HP RNA (lane 4), but it
showed no association with the mutant 59HPdm and 59HPpm
RNAs (lanes 8 and 12), indicating that both HEXIM1-binding
sites are required for in vivo recruitment of HEXIM1.
Next, we assayed the in vivo interaction of HA-HEXIM1 with
transiently expressed full-length 7SK RNAs which, similarly to the
59HPdm and 59HPpm RNAs, carried the pm or dm sequence
alterations (Figure 5B). In order to distinguish between the
ectopically expressed mutant and the endogenous wild-type 7SK
RNAs, RNase A/T1 mappings were performed using antisense
probe RNAs specific for the mutant 7SKdm and 7SKpm snRNAs.
In contrast to the endogenous 7SK snRNA, the transiently
expressed 7SKdm and 7SKpm RNAs failed to efficiently associate
with HA-HEXIM1 in vivo (lanes 5 and 10). Since docking of
HEXIM1 is a prerequisite for P-TEFb binding, neither 7SKdm
nor 7SKpm associated with P-TEFb, as demonstrated by co-IPs
with HA-tagged CycT1 (lanes 14 and 18). The finding that
disruption of either the distal or the proximal HEXIM-binding
motif of 7SK abolishes the recruitment of both HEXIM and P-
TEFb demonstrates that under in vivo conditions the distal and
proximal HEXIM-binding sites of 7SK recruit two copies of
HEXIM1 in a tightly interdependent manner.
Tat competes with HEXIM1 for 7SK snRNA binding
Demonstration that HIV Tat binds to the distal HEXIM-
binding site of human 7SK snRNA is consistent with the idea that
Tat competes with HEXIM for 7SK binding [37]. Indeed,
replacement of one copy of HEXIM with Tat would be expected
to fully disrupt the 7SK-HEXIM interaction, since in vivo
recruitment of a HEXIM-dimer requires both HEXIM-binding
sites of the 7SK snRNA (Figure 5). To confirm this hypothesis,
increasing amounts of Tat-FL was transiently expressed in HeLa
cells (Figure 6A). After IP of equal amounts of HEXIM1, co-
precipitation of 7SK was monitored by Northern blot analysis
followed by PhosphorImager quantification. The ectopically
expressed Tat-FL efficiently disrupted the interaction of the
endogenous HEXIM1 with 7SK snRNA. Since 7SK and HEXIM
can form a stable complex even in the absence of P-TEFb or other
components of the 7SK snRNP [26], we assumed that the
Figure 4. The 59 hairpin of human 7SK snRNA contains two HEXIM-binding sites. A. Detection of HEXIM-binding sites by mobility shift
assays. About 2 fmol of in vitro synthesized probe RNAs representing the entire (59HP) or the distal (Dist) and proximal (Prox) parts of the 59 hairpin of
human 7SK were incubated with increasing amounts (fmol) of recombinant HEXIM1 and analyzed on a 5% native gel. Appropriate cold RNAs were
used as specific competitors. B. In vitro interaction of mutant 7SK 59 hairpin RNAs (59HPdm, 59HPpm, 59HPdm+pm) with HEXIM1. Complexes were
analyzed on a 4% gel. C. The minimal HEXIM1-binding elements of 7SK. The in vitro HEXIM-binding capacity of a distal (DHBS) and proximal (PHBS)
fragment of the 7SK 59 hairpin was tested by mobility shift assay on a 4% gel. Sequences derived from wild-type 7SK are boxed. D. Gelshift analysis of
an artificial hairpin RNA (59HPsyn) carrying the distal and proximal HEXIM-binding motifs of 7SK. Sequences originated from the human 7SK snRNA
are boxed.
doi:10.1371/journal.ppat.1001152.g004
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tion was due to direct competition of Tat and HEXIM1 for 7SK
binding. To confirm this conclusion, mutant Tat-FL proteins, Tat-
FL(K50Q) and Tat-FL(K50A+K51A) [42], lacking TAR RNA-
binding capacity were transiently expressed in HeLa cells
(Figure 6B). Co-IP experiments demonstrated that in contrast to
the wild-type Tat (lane 2), the mutant Tat proteins failed to bind
7SK snRNA and to disrupt the interaction of HEXIM1 with 7SK
and CycT1 (lanes 3 and 4).
The experiments presented thus far demonstrate that the
RNA-binding activity of Tat is crucial for disruption of the 7SK/
HEXIM/P-TEFb snRNP. However, given that Tat can
specifically interact also with CycT1, it remains possible that
binding of Tat to the CycT1 subunit of the 7SK/HEXIM/P-
TEFb snRNP may also contribute to the disassembly of this
particle [38]. To test this possibility, we assayed the 7SK-
HEXIM1 interaction in HeLa cells expressing increasing
amounts of mutant Tat-FL(C22G) and Tat-FL(K41A) proteins
lacking CycT1-binding ability (Figure 6C). Similarly to the wild-
type Tat (see Figure 6A), both mutant Tat proteins reduced the
association of HeLa 7SK snRNA with HEXIM1 in a concen-
tration-dependent fashion. Next, the mutant Tat-FL(C22G) and
Tat-FL(K41A) proteins missing CycT1-binding capacity were
transiently expressed in HeLa G3H cells which stably expressed
HA-CycT1 [54,55] (Figure 6D). After IP of comparable amounts
HA-CycT1, co-precipitation of the endogenous 7SK snRNA and
HEXIM1 as well as the ectopically expressed Tat-FL proteins
was monitored. As expected, HA-CycT1 interacted with the
wild-type Tat-FL, but it failed to bind to the mutant Tat-
FL(C22G) and Tat-FL(K41A) proteins. More importantly,
expression of the wild-type andm u t a n tT a tp r o t e i n sl a r g e l y
reduced the association of HA-P-TEFb with 7SK and HEXIM1.
We believe that the intact 7SK/HEXIM/P-TEFb (about 25–
35%) that remained in the extracts likely derived from non-
transfected cells. Thus, we concluded that Tat can promote the in
vivo disassembly of 7SK/HEXIM/P-TEFb independently of its
CycT1-binding capacity.
The concept that Tat efficiently competes with HEXIM for
7SK binding, implies that Tat and HEXIM bind to the 7SK
snRNA in a mutually exclusive manner. To test this, the wild-type
and mutant (C22G and K41A) Tat-FL proteins were expressed in
HeLa cells (Figure 6E). Co-IP experiments showed that all Tat-FL
proteins efficiently associated with HeLa 7SK snRNA but showed
no detectable interaction with HEXIM1, demonstrating that Tat
and HEXIM interact with 7SK snRNA in a mutually exclusive
manner (lanes 4, 6 and 8). As expected, the mutant Tat proteins
failed to associate with CycT1 (lanes 6 and 8), but the wild-type
Tat-FL interacted with CycT1 (lane 4). Apparently, the wild-type
Tat associates with endogenous CycT1 predominantly in a 7SK-
independent manner [42,56], but a minor fraction of Tat may also
be involved in formation of the recently reported 7SK/Tat/P-
TEFb complex [42].
To further confirm that the CycT1-binding activity of Tat is
dispensable for disruption of 7SK/HEXIM/P-TEFb, we assayed
whether expression of Tat-FL(C22G) and Tat-FL(K41A) could
increase the nuclear level of active P-TEFb. The control and
mutant Tat-FL proteins were transiently expressed in G3H cells.
Upon IP with an anti-HA antibody, the beads with immobilized
HA-P-TEFb were incubated with a recombinant GST-CTD
protein carrying 48 C-terminal copies of the consensus CTD
repeat (YSPTSPS) in the presence of [c-
32P]ATP (Figure 6D). The
phosphorylated GST-CTD was fractionated on a SDS-polyacryl-
amide gel and the specificity of the phosphorylation reaction was
confirmed by Western blotting with an antibody specific for serine
2-phosphorylated CTD. The phosphorylation level of GST-CTD
was determined by PhosphorImager quantification. Although
Figure 5. In vivo binding of HEXIM1 to 7SK RNA. A. Interaction of HEXIM1 with mutant 7SK 59 hairpin RNAs. HA-HEXIM1 was
immunoprecipitated (IP) from extracts (E) prepared from HeLa cells also expressing 59HP, 59HPpm or 59HPdm RNAs. Interaction of HA-HEXIM1 with
the endogenous 7SK and the ectopically expressed 59HP, 59HPpm, 59HPdm RNAs was monitored by Northern blot analyses. B. Interaction of HEXIM1
and P-TEFb with mutant 7SK snRNAs. 7SKpm and 7SKdm RNAs were expressed in HeLa cells together with HA-HEXIM1 (lanes 1–10) or in G3H cells
accumulating HA-CycT1 (lanes 11–18). After IP, recovery of HA-HEXIM1 and HA-CycT1 was confirmed by Western blot analysis and co-precipitation of
the endogenous and ectopically expressed 7SK RNAs was determined by RNase A/T1 mapping. Lane C, control mapping with E. coli tRNA. Lane B,
control IP with beads alone.
doi:10.1371/journal.ppat.1001152.g005
HIV Tat Binds to the HEXIM-Binding Site of 7SK
PLoS Pathogens | www.plospathogens.org 7 October 2010 | Volume 6 | Issue 10 | e1001152comparable amounts of HA-P-TEFb (HA-CycT1) were attached
to the beads, the extracts accumulating the wild-type and mutant
Tat-FL proteins showed about 1.5 to 2-fold higher CTD
phoshorylation activity compared to the non-transfected control
extract. Given that in HeLa cells about 50% of P-TEFb is
sequestered into 7SK/HEXIM/P-TEFb, we concluded that
expression of the wild-type and mutant Tat proteins efficiently
mobilized the nuclear pool of inactive P-TEFb. These results
Figure 6. In vivo disruption of the 7SK/HEXIM/P-TEFb snRNP by HIV Tat. A. Tat disrupts the interaction of 7SK and HEXIM1. About 5610
6
HeLa cells were transfected with 0.5, 1.5, 2.5 or 3.5 mg of pTat-FL. After 48h of incubation, cell extracts were prepared, HEXIM1 was
immunoprecipitated and association of 7SK snRNA was measured by Northern blotting. NT, control IP from non-transfected cells. B. The TAR RNA-
binding capacity of Tat is essential for 7SK binding and for disruption of the 7SK/HEXIM/P-TEFb snRNP. Transiently expressed wild-type and mutant
(K50Q and K50A+K51A) Tat-FL proteins as well as endogenous HEXIM1 were immunoprecipitated and co-purification of endogenous 7SK snRNA and
CycT1 was monitored. C. Transiently expressed mutant C22G and K41A Tat proteins lacking CycT1-binding ability can disrupt the in vivo interaction of
HEXIM1 and 7SK. (For other details, see the captures to panel A) D. Tat disrupts 7SK/HEXIM/P-TEFb independently of its CycT1-binding capacity. Wild-
type and mutant (C22G and K41A) Tat-FL proteins were expressed in HeLa G3H cells stably expressing HA-CycT1. Association of HA-CycT1 with 7SK,
HEXIM1 and Tat-FL proteins was monitored by co-IP. E. Tat and HEXIM1 bind to 7SK in a mutually exclusive manner. From extracts (E) prepared from
HeLa cells non-transfected (NT) or transfected with the pTat-FL, pTat-FL(C22G) or pTat-FL(K41A) expression plasmids the accumulating Tat-FL
proteins were immunoprecipitated (IP). Distribution of 7SK snRNA and Tat-FL, HEXIM1 and CycT1 proteins was monitored with RNase A/T1 mapping
and Western blot analysis. F. Expression of Tat-FL, Tat-FL(C22G) and Tat-FL(K41A) increases the cellular level of active P-TEFb. From extracts of G3H
cells expressing Tat-FL proteins, the HA-tagged P-TEFb was immobilized on beads saturated with anti-HA antibody and incubated with a
recombinant GST-CTD protein and [c-
32P]ATP. Distribution of HA-CycT1 and Tat-FL and phosphorylation of GST-CTD at serine 2 were monitored by
Western blot analysis. CTD phosphorylation was quantified by PhosphorImager.
doi:10.1371/journal.ppat.1001152.g006
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of Tat is not required for the Tat-induced disruption of the 7SK/
HEXIM/P-TEFb snRNP and for increasing the nuclear level of
active P-TEFb.
Tat does not interact with HeLa 7SK/hnRNP particles
In HeLa cells, a fraction of 7SK snRNA is associated with
hnRNP proteins, mainly A1, A2/B1, R and Q [44,57,58]. To
exclude the formal possibility that the newly detected 7SK/Tat
RNP or at least a fraction of 7SK/Tat derived from the hnRNP-
associated pool of 7SK, we tested the effect of Tat expression on
HeLa 7SK/hnRNP complexes (Figure 7A). Transient expression
of wild-type Tat-FL had no detectable effect on the level of
association of hnRNP A1 and A2/B1 with 7SK snRNA (lanes 4
and 6), demonstrating that the hnRNP-associated fraction of 7SK
is not available for in vivo interaction with HIV Tat.
The hnRNP proteins associate with 7SK snRNA after its stress-
induced release from the 7SK/HEXIM/P-TEFb snRNP
[44,57,58]. We tested whether after Tat-mediated disruption of
7SK/HEXIM/P-TEFb, the resulting 7SK/Tat snRNP associates
with hnRNP proteins (Figure 7B). Transiently expressed Tat-FL,
together with 7SK snRNA, was immunoprecipitated and co-
purification of hnRNP A1, A2/B1, R, Q and Larp7 was tested by
Western blot analysis. Although the 7SK/Tat-FL snRNP
interacted with Larp7, none of the tested hnRNP proteins were
detected in the pellet, demonstrating that the newly described
7SK/Tat snRNP contains no hnRNP proteins.
Discussion
HIV Tat is an unconventional transcriptional activator that,
instead of targeting DNA promoter elements, recruits P-TEFb for
HIV transcription through binding to a cis-acting RNA enhancer,
the TAR RNA. Besides tethering P-TEFb to TAR, Tat also
promotes the release of active P-TEFb from the 7SK/HEXIM/P-
TEFb negative transcriptional regulatory snRNP [37,38]. In this
work, we demonstrate that Tat binds specifically to one of the two
HEXIM-binding sites of human 7SK snRNA to displace the
HEXIM homodimer on 7SK and to disrupt the 7SK/HEXIM/P-
TEFb snRNP.
The 59 hairpin of human 7SK snRNA contains two HEXIM-
binding motifs
Although all previous studies agreed that HEXIM binds to the
59 hairpin of 7SK, its precise docking site remained uncertain
[26,27,53]. Here, we demonstrated that the 59 hairpin of human
7SK snRNA contains two distinct HEXIM-binding sites which are
confined to the A34-C45/G64-A77 distal (DHBS) and the C12-
A27/U84-U95 proximal (PHBS) segments (Figure 4). Under in
vitro conditions, each HEXIM-binding motif of 7SK specifically
and independently interacts with one HEXIM molecule.
Both HEXIM-binding sites of the human 7SK snRNA contain
a stem-bulge-stem core motif (C37–C45/G64–G70 and G18-
A27/U84-C90) which are highly reminiscent of the consensus
structure of the minimal Tat-binding element of HIV TAR
(Figure 2B and 2C). Consistent with this, HIV Tat and HEXIM
proteins carry similar, positively charged, arginine-rich RNA-
binding motifs which are essential for interaction with TAR and
7SK RNAs (Figure S1). These observations, together with the
finding that Tat binds to the distal HEXIM-binding site of 7SK
(Figure 3), strongly suggest that HEXIM and Tat use similar
structural and molecular principles to recognize 7SK and TAR
RNAs. Along this line of speculation, given that Tat can bind to
the HEXIM-binding site of 7SK, it seems to be logical to
hypothesize that HEXIM can interact with the Tat-binding site of
HIV TAR [38]. However, contrary to our repeated efforts, we
failed to detect a specific interaction between HEXIM and TAR
(our unpublished data). The lack of TAR-binding ability of
HEXIM could be explained by the observations that binding of
HEXIM to 7SK snRNA, besides the TAR-like C37–C45/G64–
G70 and G18-A27/U84-C90 stem-bulge-stem core motifs, also
requires the adjacent A34-C36/C71-A77 and C12-U17/U1–U95
proximal sequences (Figure 4) [26]. Thus, HEXIM seems to form
a more intricate interaction with 7SK snRNA than it has been
reported for the Tat-TAR complex. The Tat-like RNA-binding
motifs of HEXIM proteins are N-terminally extended by highly
conserved positively charged regions which may contribute to the
specificity of the HEXIM-7SK interaction (Figure S1). Apparently,
understanding of the accurate molecular and structural back-
ground of the interaction of HEXIM and 7SK snRNA requires
further efforts.
Figure 7. The 7SK/Tat snRNP does not interact with hnRNP proteins. A. Expression of Tat has no effect on the interaction of 7SK and hnRNP
proteins. HnRNP A1 and A2/B1 were immunoprecipitated from extracts prepared from HeLa cells expressing or not expressing (NT) Tat-FL. Co-
purification of 7SK was assayed by Northern blotting. Lanes no Ab, control IPs without antibody. B. The 7SK/Tat snRNP lacks hnRNP proteins, but
associates with Larp7. Transiently expressed Tat-FL was immunoprecipitated from extracts (E) prepared from transfected (T) or non-transfected (NT)
HeLa cells. Co-IP of 7SK snRNA and hnRNP and Larp7 proteins was assayed.
doi:10.1371/journal.ppat.1001152.g007
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interdependent manner in vivo
A key achievement of the current study is the demonstration
that in living cells, assembly of the 7SK/HEXIM/P-TEFb snRNP
requires both the distal and proximal HEXIM-binding sites of
7SK, since they recruit a homodimer of HEXIM in an strictly
interdependent fashion (Figure 5). Most probably, concerted
binding of two HEXIM molecules increases the 7SK-binding
affinity of the tethered HEXIM-dimer. For example, structural
rearrangements of HEXIM induced by dimerization may promote
formation of additional molecular contacts with 7SK snRNA [59].
Interestingly, the 59 hairpins of non-vertebrate 7SK snRNAs seem
to carry only one HEXIM-docking site, suggesting that these
RNAs interact with one copy of HEXIM and P-TEFb (Figure 2C).
Acquisition of a second HEXIM-binding site that occurred
probably through sequence duplication at the early stage of
vertebrate evolution seems to be advantageous for P-TEFb
regulation, since a single 7SK/HEXIM/P-TEFb dissociation
event can mobilize two active P-TEFb molecules.
Tat binds to the distal HEXIM-binding motif of human
7SK snRNA
Transiently expressed HIV Tat specifically and efficiently
interacts with the endogenous human 7SK snRNA, indicating
that the 7SK transcriptional regulatory snRNA is the major RNA
target of Tat in the host cell (Figure 1). Tat binds to the
evolutionarily conserved C37–C45/G64–G70 internal stem-loop-
stem region of the 59 hairpin of human 7SK snRNA (Figure 3).
The newly identified Tat-binding motif of 7SK perfectly conforms
to the consensus structure of the Tat-binding motif of HIV TAR
and it is part of the distal HEXIM-binding site of 7SK.
Most of the available data are consistent with the idea that HIV
Tat competes with HEXIM1 for 7SK snRNA binding to promote
disassembly of the 7SK/HEXIM/P-TEFb snRNP and to increase
the nuclear pool of active P-TEFb. Previous in vitro reconstitution
experiments showed that Tat could disrupt pre-assembled 7SK/
HEXIM/P-TEFb complexes, resulting in stable 7SK/Tat com-
plex and free HEXIM and P-TEFb [38]. Unfortunately, because
of the high tendency of recombinant Tat protein for oxidation and
aggregate formation [48,60], in vitro competition experiments
require the usage of a great eccess of recombinant Tat, making it
difficult to measure and compare the correct in vitro 7SK-binding
affinities of Tat and HEXIM [38, our unpublished data].
Nevertheless, the in vivo competition experiments presented in this
study confirmed that Tat efficiently disrupts the association of
HEXIM1 and 7SK snRNA upon formation of 7SK/Tat snRNP
(Figure 6). Given that both HEXIM-binding sites of 7SK are
necessary for in vivo recruitment of a HEXIM homodimer,
disruption of the 7SK-HEXIM interaction at the distal HEXIM-
binding site by docking Tat is expected to release both copies of
HEXIM (Figure 5). Providing strong support to this idea, Tat and
HEXIM bind to 7SK in a mutually exclusive manner, neither the
7SK/Tat RNP contains HEXIM nor the 7SK/HEXIM complex
associates with Tat (Figure 6) [42].
Binding of HEXIM to 7SK is the first and decisive step in the
assembly of the 7SK/HEXIM/P-TEFb negative transcriptional
regulatory snRNP, because association of HEXIM and P-TEFb is
strictly 7SK-dependent [11,27,28]. Free HEXIM cannot bind to
CycT1, because its negatively charged CycT1-binding domain
forms intramolecular interactions with the adjacent positively
charged 7SK-binding motif [28]. Docking 7SK disrupts this
autoinhibitory interaction and turns HEXIM into an active
conformation ready to bind and inhibit P-TEFb. Thus, disruption
of the interaction of 7SK and HEXIM by Tat is predicted to
mobilize the 7SK/HEXIM-associated inactive pool of P-TEFb by
triggering its release from HEXIM1. In an alternative model, Tat
has been proposed to mediate 7SK/HEXIM/P-TEFb disruption
through competing with HEXIM for binding to CycT1 [37].
Arguing against this scenario, amino acid alterations which
abolished the interaction of Tat with CycT1 only slightly reduced
the ability of the mutant Tat proteins to disrupt 7SK/HEXIM/P-
TEFb and to increase P-TEFb activity in vivo (Figures 6D and 6F).
In contrast, disruption of the 7SK-binding capacity of Tat fully
abolished its ability to replace HEXIM1 and to disrupt 7SK/
HEXIM/P-TEFb (Figure 6B). Thus, although it remains possible
that the CycT1-binding activity of Tat slightly contributes to the
Tat-mediated disassembly of 7SK/HEXIM/P-TEFb, our results
indicate that the P-TEFb mobilization capacity of Tat depends
mostly, if not exclusively, on its 7SK-binding activity.
During revision of the current manuscript, the human 7SK
snRNA has been reported to form a stable complex with Tat and
P-TEFb [42]. Since 7SK can bind only one molecule of Tat and
consequently, one copy of P-TEFb (Figure 3), Tat-induced
disruption of 7SK/HEXIM/P-TEFb is expected to release at
least half of the associated P-TEFb in the form of free P-TEFb.
However, we and others observed that Tat expression converted
the nuclear pool of inactive 7SK/HEXIM1/P-TEFb into free,
active P-TEFb with a very high (75–95%) efficiency, suggesting
that the newly described 7SK/Tat/P-TEFb accumulates at low
levels (Figure 6D) [37,38]. Nevertheless, the functional significance
of the novel 7SK/Tat/P-TEFb RNP played in HIV expression
remains to be established.
Demonstration that the distal HEXIM-binding site of the
human 7SK snRNA encompasses a perfect Tat-binding motif has
an important biomedical impact. Targeting the Tat-binding site of
HIV TAR RNA with small-molecule drugs to block Tat-mediated
transactivation is a very attractive approach for anti-viral therapy
[61]. However, potential anti-HIV drugs with strong TAR-
binding capacity are expected to interact also with the distal
HEXIM-binding motif of 7SK and therefore, to promote the
disassembly of 7SK/HEXIM/P-TEFb that shifts the P-TEFb
equilibrium toward the active form. Since increased P-TEFb
activity may have deleterious effects [16,62], therapeutic targeting
of HIV TAR requires the design of ligands which are highly
specific for the TAR RNA. So, our results suggest that drug-
mediated therapeutic inhibition of Tat-TAR interaction requires
more precautions than anticipated before.
Materials and Methods
General procedures
Unless stated otherwise, all techniques used for manipulation of
DNA, RNA oligonucleotides and proteins were performed
according to standard laboratory procedures. The identity of all
plasmid constructs was verified by sequence analysis. Human
HeLa and G3H cells, the latter was provided by Dr Q. Zhou [63],
were grown in Dulbecco’s modified Eagle medium supplemented
with 10% fetal calf serum (Invitrogen). Expression plasmids were
introduced into HeLa and G3H cells by using the FuGENE
transfection reagent (Roche).
Plasmid construction
Construction of the p7SK, p59HP and pHA-HEXIM1 expression
plasmids has been described [26]. The pTat-FL, pTat-FL(C22G),
pTat-FL(K41A), pTat-FL(K50Q) and pTat-FL(K50A+K51A) plas-
mids have been provided by Dr M. Benkirane [42,64]. The p7SKdm,
p7SKpm, p59HPdm, p59HPpm, p59HPpm+dm, p59HP(U40–U41),
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p59HP(A43) and p59HP(G42-A43) 7SK expression plasmids were
generated by PCR-mediated mutagenesis using p7SK and p59HP as
templates.
RNA analysis
RNA isolation from HeLa and G3H cells and cell extracts has
been described [26]. RNAs co-immunoprecipitated with Tat-FL
were 39 end-labeled with [59-
32P]pCp and T4 RNA ligase before
fractionation on a 6% sequencing gel. After elution from the gel,
the labeled 7SK snRNA was partially digested with RNase T1 in
25 mM Na-citrate, pH 5.0, and 7 M urea at 55uC. Partial RNA
hydrolysis was performed in deionized formamide containing
0.4 mM MgCl2 at 100uC. For Northern blot analysis, RNAs were
size-fractionated on a 6% denaturing gel and electroblotted onto a
Hybond-N nylon membrane (Amersham Biosciences). The filters
were probed with labeled oligonucleotides complementary to the
human 7SK snRNA from U92 to G111, from G272 to C291 or
from C48 to C67. To generate sequence-specific antisense RNA
probes for mapping of 7SK, 7SKpm, and 7SKdm RNAs, the
corresponding expression plasmids were linearized with PstI and
used as templates for in vitro transcription with T7 RNA
polymerase. RNase A/T1 protection analysis has been described
[26].
Complex formation and bandshift assays
To generate template DNAs for in vitro synthesis of internally
32P-labeled 59HP, Dist, 59HPdm, 59HPpm and 59HPdm+pm
probe RNAs, the corresponding fragments of the p59HP,
p59HPdm, p59HPpm and p59HPdm+pm plasmids were amplified
with appropriate oligonucleotides which also incorporated the T7
promoter. Template DNAs for synthesis of Prox, DHBS, PHBS
and 59HPsyn were obtained by annealing of appropriate synthetic
oligonucleotides followed by cloning into the pBluescribe plasmid.
Recombinant HEXIM1 was purified as described [26]. Tat(38–
72) peptide was synthesized by PolyPeptide Group [51]. RNA-
protein complexes were formed in 50 mM Tris-HCl, pH 8.0,
100 mM NaCl, 14.4 mM 2-mercaptoethanol in the presence of
20 ng/ml of E. Coli tRNA at RT. The complexes were analyzed
on 4% or 5% polyacrylamide gels (29:1 acrylamide:bis-acrylamide)
containing 2.5% glycerol in 0.56TBE.
In vitro CTD phosphorylation
Human G3H cells transiently expressing wild-type or mutant
(C22G and K41A) Tat-FL proteins were lysed in buffer A (20 mM
HEPES, pH 7.9, 150 mM NaCl, 1.5 mM MgCl2, 1 mM DTT,
0.5 mM EDTA, 0.05% Nonidet P40) supplemented with 10 U/
ml of RNasin (Promega) and protease inhibitor cocktail (Roche).
After centrifugation at 10,0006 g for 10 min, the extracts were
incubated with anti-HA-agarose beads (Sigma) for 1 hour. The
beads were washed five times in buffer A, resuspended in 100 mlo f
buffer A and incubated with 2 mg of recombinant GST-CTD
containing 48 consensus CTD repeats (YSPTSPS) and 10 mCi of
[c-
32P]ATP (6000 Ci/mmol) at 30uC. Phosphorylation of GST-
CTD was measured by PhosphorImager quantification after
fractionation on 8% SDS/polyacrylamide gel.
Supporting Information
Figure S1 Comparison of the positively charged RNA-binding
motifs of HIV Tat and HEXIM proteins. HIV Tat (AAC29057),
human (NM_006460; NM_144608), Xenopus laevis (NP_001090038),
Salmo salar (NP_001133431), Danio rerio (NP_001091859), Ciona
intestinalis (XP_002128947), Ixodes scapularis (XP_002408010), Strongylo-
centrotus purpuratus (XP_792438) and Nematostella vectensis (XP_
001636835) HEXIM proteins were obtained from the GenBank.
The regions conserved in Tat and HEXIM proteins are boxed.
Found at: doi:10.1371/journal.ppat.1001152.s001 (0.17 MB
TIF)
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